ProKidney (PROK) vs Valneva (VALN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Valneva (VALN) has outperformed ProKidney (PROK) over the past year, losing 44.9% versus a loss of 47.0%. Over five years, VALN leads with a -79.1% price change compared with -84.1% for PROK. ProKidney is the larger company by market cap ($626.7 million vs $556.6 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PROK | VALN |
|---|---|---|
| Share price | $1.57 | $5.87 |
| Market cap | $626.72M | $556.61M |
| 1-day change | -1.88% | +0.17% |
| YTD return | -29.91% | -33.45% |
| 1-year return | -46.96% | -44.88% |
| 5-year return | -84.09% | -79.07% |
| Forward P/E | — | 4.93 |
| EPS (TTM) | $-0.55 | $-2.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.48 | $12.18 |
| 52-week low | $1.30 | $4.75 |
| Distance from 52-week high | -54.89% | -51.81% |
| Average volume | 1.31M | 77.94K |
| Shares outstanding | 208.93M | 94.82M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
PROK vs VALN FAQ
Which is bigger, ProKidney or Valneva?
ProKidney (PROK) is larger, with a market capitalization of $626.72M compared with $556.61M for Valneva (VALN).
Which stock has performed better over the past year, PROK or VALN?
VALN returned -44.88% over the past 12 months, compared with -46.96% for PROK (price return, excluding dividends). Past performance does not predict future results.
Are ProKidney and Valneva in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.